Cetirizine: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
(One intermediate revision by one other user not shown) | |||
Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Dosing and Administration== | ==Dosing and Administration== | ||
Line 16: | Line 16: | ||
{{FDA}} | {{FDA}} | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Latest revision as of 23:42, 8 August 2012
WikiDoc Resources for Cetirizine |
Articles |
---|
Most recent articles on Cetirizine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cetirizine at Clinical Trials.gov Clinical Trials on Cetirizine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cetirizine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cetirizine Discussion groups on Cetirizine Patient Handouts on Cetirizine Directions to Hospitals Treating Cetirizine Risk calculators and risk factors for Cetirizine
|
Healthcare Provider Resources |
Causes & Risk Factors for Cetirizine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Synonyms / Brand Names:
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
Adults and Children 12 Years of Age and Older: The recommended dose of ZYRTEC-D 12 HOUR™ Extended Release Tablets is one tablet twice daily for adults and children 12 years of age and older.
Dose Adjustment for Renal and Hepatic Impairment: In patients with decreased renal function(creatinine clearance 11-31 mL/min), patients on hemodialysis (creatinine clearance less than 7 mL/min), and in hepatically impaired patients, a dose of one tablet once daily is recommended.
ZYRTEC-D 12 HOUR™ Extended Release Tablets may be given with or without food and should be swallowed whole, avoiding breaking or chewing the tablet.
Adapted from the FDA Package Insert.